The pharmacist answer on stocking it was not relevant, obviously he doesn't make policy. The fact that NEXAFED doesn't even have a competitive price is what should have captured you eagle eyed geniuses.....
I asked him since they were buying KERR Pharmacies would they carry Nexafed? He looked it up on his computer. He laughed and said it's $11.90 3 times more than Sudafed, he said either all Walgreens will may carry it or it would be dropped.
Here's the facts. Sudafed has a 1Billion Dollar a year business on their Meth asisting business. To disengage the addicts decreases buyers by a %, to continue to lose market share costs $. weighing the losses vs. market change over to legit users creates a loss..but to what degree? There is profit in abuse don't doubt it! But , Nexafed is their saving grace, should they wish to "Partner"...
With millions in salary for Jones and Clemons, they could have skipped a view dinners and purchased their own product to raise this pathetic number. In fact. I could have PAID Jones and Clemons 1/3 as as much to go door to door selling Nexafed in one state and triple that number. This is beyond pathetic, and IMHO feel they have been sitting on their hands for the last quarter. 1400+ distribution Pharmacies and sold a profit of $1000. That's roughly one at every 3 pharmacies. Even Hilary Clinton bought thousands of her own books to make it look good. If I was Jones i would have bought 10,000. units with his over compensation and donated it to the Clinch Mountain poor. Point is, they did nothing, and the question is WHY? Suppress the the stock price? We know PFE hasn't put forward their best. Admitting, We will expand ours sales...Well #$%$ have these asshles bee doing for 2 years. Yes, I know. Putting their hopes and dreams into Remoxy. 3 Strikes and gone PFE...How about J & J the main contributor to meth dealers IMHO , without any abuse action in their product to stop the spread of 2 liter labs. Yes Acur needs a new Partner, CEO, and Face for the company. Acura Pharma is paying administration costs to deadbeats soaking up the bank, and doing nothing to earn it.
You are so right. I keep my eyes on the ball. Product , and distribution. There are only two directions , sell the company or sell the product(s). Both directions are UP. If Skelly sells, it only signals he's not selling the company soon, but the last Sec filing mostly said that. If we get Walmart, we could be seeing $12. a share Cross your fingers guys...
Don't forget the 75 million in approved stock sales to create cash to increase production..Now do your math:)
Pfe has been putting all their cookies into Remoxy, and treating Acura like a stepchild. Now, with Oxecta the only game in town, and for a few more years at least, maybe we get our Propers! Also funny is how Sudafed is restricted by amounts and prescriptions only, and Nexafed bought with no restrictions..We are begining to steal Johnson & Johnsons Billion dollar Baby
ACUR 's very first earnings quarter JUST happened. With each quarters earnings rising, so will share price, and resistance levels. It's like a New Mall, with first renter, slowly but surely we'll fill pharmacy shelves and sell more and more, add more products, and grow our value/share price.
This is an investment stock,This last quarter was it's first earnings! Half my thousands of shares are in a Roth IRA, and traditional IRA. This stock will easily see $18. a share once its' pipeline is on the shelves,even more if we drop Pfe, and find a decent partner. But this is a new and upcoming company, with potential to grow or sell its self, but patience is a must to make money here.
One more big 10 coming according to Conf. Call
IMHO, Pfe is heavily invested in REmoxy (PTIE) and that's their baby. They are just sitting on Acura 's patent,til Remoxy can be sold. Investor Relations says they're not a good partner, and they are looking for another.
I have called all Gov. office of fly over States with Meth problems. Asking Why aren't they onboard with ACURA and the FDA...You should do the same. Said about Oxecta, PFE is suppressing the drug to push Remoxy IMHO
Check your math. 45 M shares x 6 =270M . According to investor relations last years nominal sales resulted in no more than 30M, and better sales next year of Oxecta.Nominal of 30M x 20 life of one product patent is 600M or 12+ a share for "ONE" product, and their least productive. Nexafed is expected (Now pushed by FDA) to fetch 50M times 20 life of patent 1Billion conservatively.
First year sales were nominal and they were factored in to the earlier milestone of 30M. The actual Royalty payment will be on the anniversary of the second year
They have had the chance to let Pro-Golfers take the lead and play a professional game, but chose to take their mini-Golf putters and take their chances. IMHO, we have a long road ahead.
That's more shares for us. But you must admit, Care Cap, has no idea if and when Walmart or Walgreens picks up NExafed.